Philips NV : The sleep apnea case makes a brutal comeback

As a result, the FDA has instructed Philips to carry out further risk testing. In June 2021, millions of breathing aids and ventilators used for sleep apnea had been recalled due to a risk of degradation and toxicity of a foam component that could become carcinogenic. The news sent Philips shares in…
© MarketScreener.com 2023